Insiders / Stokes Frank

Stokes Frank

CIK 1782815personinsider

Companies

2

First seen

Jan 14, 2026

Last activity

Jun 22, 2026

Companies

Company	Role	Shares held	Peak held	Trades	Latest
Castle Biosciences, Inc. · CSTL	Executive	60,085	73,018	13	—
Exagen Inc. · XGN	Director	—	112,500	1	—

All securities held

5 positions · latest reported per filing

Company	Security	Shares	As of
Castle Biosciences, Inc.	Common Stock	60,085	Mar 5, 2026
Castle Biosciences, Inc.	Restricted Stock UnitsDerivative	35,878	Mar 4, 2026
Castle Biosciences, Inc.	Stock option (right to buy)Derivative	14,912	Mar 4, 2026
Castle Biosciences, Inc.	Performance-Based Stock UnitDerivative	8,124	Jan 12, 2026
Exagen Inc.	Stock Option(right to buy)Derivative	112,500	Jun 9, 2026

Activity

InsidersInstitutions

This person's insider trades (Form 4), across every company.

Date	Action	Company	Value	Shares Δ	Position after	Impact
Mar 4, 2026	Other	CSTL Castle Biosciences, Inc. Common Stock	$302.3K	-11K -14.70%	62,286 0.20% of shares	low
Mar 5, 2026	Sell	CSTL Castle Biosciences, Inc. Common Stock	$167.9K	-6K -9.08%	60,085 0.20% of shares	medium
Mar 3, 2026	Sell	CSTL Castle Biosciences, Inc. Common Stock	$144.8K	-5K -8.91%	54,183 0.18% of shares	medium
Mar 3, 2026	Other	CSTL Castle Biosciences, Inc. Common Stock	$99.6K	-4K -6.88%	48,872 0.16% of shares	low
Mar 3, 2026	Sell	CSTL Castle Biosciences, Inc. Common Stock	$47.3K	-2K -3.14%	52,483 0.17% of shares	low
Mar 4, 2026	Exercise	CSTL Castle Biosciences, Inc. Common Stock	$12.8K	+4K +6.10%	66,086 0.22% of shares	low
Jan 12, 2026	Grant	CSTL Castle Biosciences, Inc. Common Stock	$0	+8K +16.14%	58,450 0.19% of shares	low
Jun 9, 2026	Grant	XGN Exagen Inc. Stock Option(right to buy)	—	+38K +50.00%	112,500 0.46% of shares	low
Mar 4, 2026	Exercise	CSTL Castle Biosciences, Inc. Stock option (right to buy)	—	-4K -20.31%	14,912 0.05% of shares	low
Mar 4, 2026	Exercise	CSTL Castle Biosciences, Inc. Restricted Stock Units	—	-12K -25.00%	35,878 0.12% of shares	low